论文部分内容阅读
Objective Serotonergic and noradrenergic systems have been implicated in the pathophysiology of depression.Both neurotransmitter systems have been targeted in antidepressant therapy.Pharmacological agents able to simultaneously act on both pathways have gained more acceptances,possibly due to their broader range of therapeutic effect.